| |
| |
|
| Insider
Information: |
Parschauer Karah Herdman |
| Relationship: |
Director |
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
105,047 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,281,434 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
105,047 |
|
|
| Total
Value |
$3,281,434 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
12
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
10
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -109.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-03-01 |
67,340 |
2016-06-20 |
0 |
Premium* |
|
|
Evolus Inc |
EOLS |
Director |
2024-02-07 |
37,707 |
2021-02-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2020-09-23 |
4 |
OE |
$48.43 |
$484,300 |
D/D |
10,000 |
34,293 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2020-10-06 |
4 |
OE |
$48.43 |
$484,300 |
D/D |
10,000 |
34,293 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2020-10-30 |
4 |
OE |
$54.50 |
$539,714 |
D/D |
9,903 |
33,871 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2020-08-17 |
4 |
OE |
$54.50 |
$545,000 |
D/D |
10,000 |
36,663 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2020-10-08 |
4 |
OE |
$54.50 |
$545,000 |
D/D |
10,000 |
34,293 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2021-03-01 |
4 |
S |
$138.17 |
$548,535 |
D/D |
(3,970) |
30,227 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2021-09-08 |
4 |
S |
$100.65 |
$738,368 |
D/D |
(7,336) |
28,668 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2020-09-23 |
4 |
AS |
$85.00 |
$850,000 |
D/D |
(10,000) |
24,293 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2020-10-06 |
4 |
AS |
$90.00 |
$900,000 |
D/D |
(10,000) |
24,293 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2020-10-08 |
4 |
AS |
$95.00 |
$950,000 |
D/D |
(10,000) |
24,293 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2020-10-30 |
4 |
AS |
$100.12 |
$991,488 |
D/D |
(9,903) |
24,061 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP and General Counsel |
• – – |
2020-08-17 |
4 |
S |
$88.39 |
$1,093,884 |
D/D |
(12,370) |
24,293 |
0 |
% |
|
62 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
